Trademarkia Logo

Australia

AU$
REBLOZYL
Registered: Registered/protected

Last updated on 17 May 2024

Owner Info

Celgene Corporation

86 Morris Avenue

Summit, NJ, 07901 UNITED STATES OF AMERICA,

Serial Number

2394898 filed on 9 Oct 2023

Correspondent

Spruson & Ferguson

GPO Box 3898,

Sydney, NSW, 2001 AUSTRALIA,

REBLOZYL

Classification Information


Class [005]
Pharmaceutical preparations for use in the treatment of anemia, beta thalassemia, blood disease, cancer.

Mark Details


Serial Number

2394898

Registered On

9 Oct 2023

Renewal On

9 Oct 2033

Mark Type

FIGURATIVE

Legal History


Show more

Status DateAction Taken
17th May 2024IP Right Registered correspondence sent
17th May 2024IP Right Registration Published
17th May 2024Status change to Registered/Protected
10th Mar 2024Application Accepted correspondence sent
10th Mar 2024IP Right has been Examined
10th Mar 2024IP Right Acceptance Published
22nd Nov 2023Early Acceptance Notice correspondence sent
22nd Nov 2023Status change to Accepted
13th Oct 2023IP Right Filed correspondence sent
12th Oct 2023Awaiting examination